Skip to main content
. 2021 Jun;103(6):444–451. doi: 10.1308/rcsann.2020.7092

Table 2 .

Postoperative outcomes (n = 316)

Outcome Value
(n) (%)
Reoperation:    
 No reoperation required 308 97.5
 Reoperation for bleeding or tamponade 6 1.9
 Reoperation for valve problems including SAM 2 0.6
New postoperative stroke:    
 Permanent 3 1.0
 Transient 5 1.6
New haemofiltration 3 0.9
Discharge destination:    
 Home 296 93.7
 Convalescence (non-acute hospital) 6 1.9
 Other acute hospital 7 2.2
 Patient deceased 7 2.2
Duration of ventilation:    
 <12 hours 290 91.8
 <24 hours 16 5.1
 >24 hours 10 3.2
Intensive care stay/days, median [IQR] 1.00 [1.00, 1.00]
Donor blood use 14 4.4
Blood loss first 12 hours, median [IQR] 220 [160, 340]
Inotropes use 91 28.8
Arrhythmias:    
 None 257 81.3
 Permanent pacemaker 5 1.5
Myocardial infarction 0 0.0
Pulmonary complications:    
 None 287 90.8
 Tracheostomy and long term wean 4 1.2
GI complications:    
 None 313 99.1
 Other 2 0.6
 Upper GI bleed 1 0.3
Acute kidney injury (%) 9 2.8
Postoperative stay/days, median [IQR] 6.00 [5.00, 8.00]
Multisystem organ failure 3 0.9
Cause of death:    
 Cardiac 1 0.3
 Neurological 1 0.3
 Respiratory 3 1.0
 Septicaemia 2 0.6
Patient status:    
 Alive 309 97.8
 Died in hospital 7 2.2

GI, gastrointestinal; IQR, interquartile range; SAM, systolic anterior motion